MMRC Names MDS Pharma Services as Preferred CRO
News Apr 13, 2006
In this role, MDS Pharma Services will manage and execute MMRC pre-clinical and clinical research efforts, including data management related to the tissue accrual into the MMRC Tissue Bank.
The MMRC will also recommend MDS Pharma Services to industry partners as additional protocols are brought through the Consortium.
"MDS Pharma Services offers a full spectrum of advanced scientific and technological expertise to significantly accelerate each step of the drug discovery and development pathways," said Nancy Sumberaz, President, the MMRC.
"We are proud to consider MDS Pharma Services a true partner in our efforts to bring new therapeutic options to patients as quickly as possible."
"MDS Pharma Services is honored to have been chosen by the MMRC and we are ready to bring our global capabilities and oncology expertise to bear on the effort to fight multiple myeloma," says Alan Morgan, Vice President and General Manager for Global Clinical Development, MDS Pharma Services.
Key Ingredient in Diabetes Drug Modified to Improve Side EffectsNews
Improved medications for Type 2 diabetes are one step closer thanks to a new discovery reported this week. By modifying the key ingredient in current diabetes drugs, the researchers produced a compound that was effective for hyperglycemia in animal trials, yet without the most problematic side effects of current drugs.READ MORE
Chili Pepper Derived Anti-Obesity Drug Shows Promise in Animal TrialsNews
A novel drug based on capsaicin, the compound that gives chili peppers their spicy burn, caused long term weight loss and improved metabolic health in mice eating a high fat diet.READ MORE
5th edition of the International Conference Clinical Oncology and Molecular Diagnostics
Jun 17 - Jun 18, 2019